The purpose of this study is to gather information about the long-term effects and safety of
treatment with Rapamune in transplant patients.
- Transplantation patients treated with sirolimus (Rapamune).
- Patients must be able to give informed consent.
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: